Nonsmall Cell Lung Cancer
Oncology
Prevalence
6.0 / 100K
Incidence
8.0 / 100K/yr
1 drug in development·1 company·3 clinical trials
Drug Pipeline by Phase
Phase 1(1)
Frequently asked questions
How many drugs are in development for Nonsmall Cell Lung Cancer?
BioSniper tracks 1 drug in development for Nonsmall Cell Lung Cancer across 1 company.
How many clinical trials target Nonsmall Cell Lung Cancer?
There are 3 clinical trials targeting Nonsmall Cell Lung Cancer tracked by BioSniper.
What is the prevalence of Nonsmall Cell Lung Cancer?
The estimated prevalence of Nonsmall Cell Lung Cancer is approximately 6.0 per 100,000 population.
Deep-dive into Nonsmall Cell Lung Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis